AMICUS THERAPEUTICS, INC. — Director's Dealing 2012

Jun 15, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-06-13

Reporting Person: BARRETT M JAMES (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-13	Director Stock Option (Right to Buy)	$4.79	A	15000	Acquired	2022-06-13	Common Stock (15000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in full on the date of the issuer's annual meeting of stockholders that occurs in 2013, provided that if the Reporting Person ceases to be a director of the issuer, the stock option shall cease to be exercisable in any respect not later than ninety (90) days following that event.